IV

AIM ImmunoTech Announces Report of Complete Topline Data from Roswell Park Comprehensive Cancer Center Study Evaluating Ampligen® as a Component of a Chemokine-Modulating (CKM) Regimen, with Paclitaxel, for the Treatment of Early-Stage Triple Negative Bre

Retrieved on: 
Monday, September 11, 2023
CKM, TNBC, Roswell Park Comprehensive Cancer Center, Science of team science, AIM, IV, Senior, DL, Safety, DLT, SITC, Paclitaxel, Immunotherapy, Celecoxib, Cyclophosphamide, Trae tha Truth, Roswell Park, Research, AC, Neoplasm, Biomarker, Doctor of Philosophy, PCR, Assistant, NAC, Patient, Blood, Rintatolimod, Society for Immunotherapy of Cancer, Financial toxicity, Immunology, Infrared spectroscopy correlation table, Physician, NYSE, Medical imaging, Pharmaceutical industry, MD

OCALA, Fla., Sept. 11, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that Roswell Park Comprehensive Cancer Center has reported the complete topline data from its Phase 1 study evaluating Ampligen® (rintatolimod) as a component of a CKM regimen for the treatment of early-stage triple negative breast cancer (TNBC). The complete topline results are now available on ClinicalTrials.gov: NCT04081389.

Key Points: 
  • The complete topline results are now available on ClinicalTrials.gov: NCT04081389 .
  • “We are pleased to bolster our growing body of data from Ampligen and the results demonstrated in the Phase 1 study with the completed topline data report now in hand.
  • Secondary endpoints included pCR rate where 5/9 (56%) of patients attained pCR and 1 more patient attained ypTmic.
  • For more information about the Phase 1 study, visit ClinicalTrials.gov: NCT04081389 .

Virginia Oncology Associates Chooses the Ivenix Infusion System from Fresenius Kabi

Retrieved on: 
Thursday, September 14, 2023
Oncology, Nursing, Medical Supplies, Health, Medical Devices, Practice Management, Pharmaceutical, Therapy, Fresenius (company), IV, Pharming, EMR, Cancer, Multimedia, VOA, Patient, Physician, Safety, Medical device

Fresenius Kabi announced today it has signed an agreement with Virginia Oncology Associates (VOA) under which VOA will purchase the Ivenix Infusion System to deliver medications for its patients.

Key Points: 
  • Fresenius Kabi announced today it has signed an agreement with Virginia Oncology Associates (VOA) under which VOA will purchase the Ivenix Infusion System to deliver medications for its patients.
  • View the full release here: https://www.businesswire.com/news/home/20230914778437/en/
    Virginia Oncology Associates (VOA) is using the Ivenix Infusion System from Fresenius Kabi to deliver medications to VOA patients.
  • Fresenius Kabi and VOA have agreed to work together to integrate the Ivenix Infusion System with VOA’s electronic medical record (EMR) system.
  • The built-in integration engine within the Ivenix Infusion System supports secure interoperability with leading electronic medical records (EMR) systems.

ivWatch Announces Attendance at Key Vascular Access and Nursing Conferences This Fall

Retrieved on: 
Wednesday, September 13, 2023
Magnet, IV, Senior, ANCC, Oregon Convention Center, American Nurses Credentialing Center, Research, Many, PIV, Conspiracy, NNP, Hospital, Patient safety, Risk, Intravenous therapy, AVA, NEWS, RN, Culture, 2023 Conference USA baseball tournament, Conference, Medical device, Nightclub, Hotel

NEWPORT NEWS, Va., Sept. 13, 2023 /PRNewswire/ -- ivWatch, LLC, the IV safety company, today unveiled a packed lineup of fall conference exhibitions and speaking engagements, including the Association for Vascular Access (AVA) 2023 Conference in Portland, Oregon, American Nurses Credentialing Center's (ANCC) National Magnet & Pathway to Excellence Conferences in Chicago, IV Summit 23 from IVTEAM in Nottingham, England, and IV Therapy Summit in London. ivWatch CEO Gary Warren and CTO Jason Naramore are among the speakers at these upcoming events.

Key Points: 
  • ivWatch CEO Gary Warren and CTO Jason Naramore are among the speakers at these upcoming events.
  • ANCC National Magnet & Pathway to Excellence Conferences , McCormick Place Convention Center, Chicago, October 12-14 – Booth 2018
    ivWatch will be showcasing its IV monitoring technology at the booth.
  • Many hospitals are utilizing ivWatch as part of quality improvement projects, including those for magnet submissions.
  • To learn more about the ivWatch patient monitoring system for IV infiltrations and extravasations visit: https://www.ivwatch.com/tech-overview/ .

Moldy Dinner Scraps Nearly Kill Hungry Dog

Retrieved on: 
Wednesday, September 13, 2023
Seizure, Rib, Anticonvulsant, Food, Central nervous system, Tremor, IV, Life, Dog, Prognosis, Shivering, Xylitol, Wind, Sugar, Animal, Poisoning, Twitch, Contra body movement, Pet, Toxicology, News, Animal husbandry, Fast food

MINNEAPOLIS, Sept. 13, 2023 /PRNewswire/ -- As summer begins to wind down, festive outdoor barbeques transition to indoor crock-pot feasts. After that slowly simmering supper has been served, however, the toxicology experts at Pet Poison Helpline want to warn pet lovers not to leave the leftovers out where an animal can find them.

Key Points: 
  • "Toxins called tremorgenic mycotoxins can form in spoiled, moldy food.
  • Symptoms include central nervous system and gastrointestinal signs, shivering, twitching, loss of control of body movements, high body temperature and seizures.
  • After slow-cooking a crock-pot full of ribs, Counce took the container of old, moldy sauce to the back yard to clean it out.
  • After discussing what had happened, and Sugar's symptoms, the toxicologists determined that Sugar was reacting to the moldy barbeque sauce, not xylitol.

Gates Foundation Goalkeepers Report Says Seven Innovations Could Save 2 Million Mothers and Babies by 2030

Retrieved on: 
Tuesday, September 12, 2023
Goalkeeper, United Nations Sustainable Development Group, Poverty, Pregnancy, IV, Education, Infection, Policy, COVID-19, Woman, Global health, Research, Melinda French Gates, Maternal death, Bill & Melinda Gates Foundation, Sustainable Development Goals, Mother, Death, Azithromycin, ACS, Child, Anemia, Internal bleeding, Bill, Mortality, Infant, United, Health, Food security, Coal, Birth control, Nursing, Dietary supplement

SEATTLE, Sept. 12, 2023 /PRNewswire/ -- The Bill & Melinda Gates Foundation today released its seventh annual Goalkeepers Report, describing where the world has collectively fallen short at the halfway point for achieving the United Nations Sustainable Development Goals (SDGs), and where innovation and investment can fuel progress, particularly in the fight against the global epidemic of maternal and child mortality.

Key Points: 
  • Co-authored by foundation Co-chairs Melinda French Gates and Bill Gates, the report highlights new data that shows the potential of scaling up global access to seven innovations and practices that address the leading causes of maternal and newborn deaths.
  • "By making new innovations accessible to those who need them most, 2 million additional lives could be saved by 2030, and 6.4 million lives by 2040.
  • That's 2 million families spared an unimaginable heartbreak—and 2 million more people who can shape and enrich our world," they write.
  • Many of the life-saving innovations and practices highlighted in the report can be delivered by midwives and birth attendants in communities.

Gates Foundation Goalkeepers Report Says Seven Innovations Could Save 2 Million Mothers and Babies by 2030

Retrieved on: 
Tuesday, September 12, 2023
Goalkeeper, United Nations Sustainable Development Group, Poverty, Pregnancy, IV, Education, Infection, Policy, COVID-19, Woman, Global health, Research, Melinda French Gates, Maternal death, Bill & Melinda Gates Foundation, Sustainable Development Goals, Mother, Death, Azithromycin, ACS, Child, Anemia, Internal bleeding, Bill, Mortality, Infant, United, Health, Food security, Coal, Birth control, Nursing, Dietary supplement

SEATTLE, Sept. 12, 2023 /PRNewswire/ -- The Bill & Melinda Gates Foundation today released its seventh annual Goalkeepers Report, describing where the world has collectively fallen short at the halfway point for achieving the United Nations Sustainable Development Goals (SDGs), and where innovation and investment can fuel progress, particularly in the fight against the global epidemic of maternal and child mortality.

Key Points: 
  • Co-authored by foundation Co-chairs Melinda French Gates and Bill Gates, the report highlights new data that shows the potential of scaling up global access to seven innovations and practices that address the leading causes of maternal and newborn deaths.
  • "By making new innovations accessible to those who need them most, 2 million additional lives could be saved by 2030, and 6.4 million lives by 2040.
  • That's 2 million families spared an unimaginable heartbreak—and 2 million more people who can shape and enrich our world," they write.
  • Many of the life-saving innovations and practices highlighted in the report can be delivered by midwives and birth attendants in communities.

Cunningham Bounds: Alabama Supreme Court Upholds $10M Wrongful Death Judgment Against Springhill Medical Center

Retrieved on: 
Thursday, September 7, 2023
Sentinel, Well, Traffic, Research Institute of Healthcare Organization and Medical Management of Moscow Department of Healthcare, IV, Personal injury, FDA, Depression, Accreditation, Family, Joint Commission, Supreme Court of Alabama, Nursing, Springhill Medical Center, Sportspeople who died during their careers, JCAHO, Insurance

Mr. West accidentally cut his left thumb with a table saw and went to Springhill Medical Center.

Key Points: 
  • Mr. West accidentally cut his left thumb with a table saw and went to Springhill Medical Center.
  • Cunningham Bounds remains focused on and committed to fighting for plaintiffs in cases involving serious personal injury, wrongful death, medical malpractice, products liability, and complex civil litigation.
  • For more information on Cunningham Bounds, visit: www.cunninghambounds.com
    The law firm of Cunningham Bounds has offices in Mobile, Alabama and Atlanta, Georgia and has been representing plaintiffs for over 60 years.
  • Today the firm continues its tradition of representing victims in cases involving catastrophic personal injury, industrial accidents, defective products, truck and automobile accidents, and medical malpractice.

Hyloris Pharmaceuticals Reports 2023 Half-Year Results and provides Business Outlook

Retrieved on: 
Wednesday, September 6, 2023
US Foods, CET, IV, Hypophosphatemia, D, Lidocaine, Hospital, Heart, Collection, Atrial fibrillation, NDA, Allergic rhinitis, Acute coronary syndrome, CMO, Tranexamic acid, Progress, Cardiology, Aspirin, Disease, IC/BPS, Death, Rhinitis, Patient, ACS, Bone mineral, Patent, Blood, Brussels Stock Exchange, Risk, PDUFA, TXA, Growth, Metolazone, FDA, Hikma Pharmaceuticals, RTU, Allergen, Arrhythmia, Safety, Heparin, Dofetilide, Bookkeeping, Vaccine, Pharmaceutical industry, Health insurance, Fine chemical, AFT, Sotalol

A potential approval date for the US market was set for 17 October 2023 by the U.S. Food & Drug Administration.

Key Points: 
  • A potential approval date for the US market was set for 17 October 2023 by the U.S. Food & Drug Administration.
  • In January 2023, Hyloris in-licensed HY-088, a product candidate targeting hypophosphatemia, a serious condition causing patients to have low level of phosphate in the blood.
  • For Dofetilide IV, the results of the pivotal clinical study, allowing regulatory submission, are expected by the summer of 2024.
  • Hyloris aims to improve ease of administration and dosage control, and thus potentially improving clinical outcome.

Freedom-Based Clinic WE THE PEOPLE HEALTH AND WELLNESS CENTER Launches in Venice, Florida

Retrieved on: 
Friday, September 1, 2023
Armenian American Wellness Center, Pediatrics, ARNP, IV, The Center, Patient, DPC, Attention, Internal medicine, Sunshine State, Health, Environment, People's Health Movement, Hospital, Pharmaceutical industry, Nursing

VENICE, Fla., Sept. 1, 2023 /PRNewswire/ -- Today marks the launch of a new, freedom-based health and wellness clinic in the Sunshine State. We The People Health and Wellness Center is proud to unveil its visionary Direct Primary Care (DPC) clinic in Venice.

Key Points: 
  • VENICE, Fla., Sept. 1, 2023 /PRNewswire/ -- Today marks the launch of a new, freedom-based health and wellness clinic in the Sunshine State.
  • We The People Health and Wellness Center is proud to unveil its visionary Direct Primary Care (DPC) clinic in Venice.
  • Today marks the launch of a new, freedom-based health and wellness clinic in the Sunshine State.
  • We The People Health and Wellness Center boasts state-of-the-art facilities, ensuring a comfortable and welcoming environment for all patients.

The Wellness Lab, Health & Wellness Experts, Join Exclusive Haute Beauty Network

Retrieved on: 
Thursday, August 31, 2023
Heart, Mineral, Emergency medicine, IV, Nutrient, Nursing, Medical director, PRP, Malnutrition, Health, Medical device

NAPLES, Fla., Aug. 31, 2023 /PRNewswire-PRWeb/ -- Welcome to The Wellness Lab, where our team of dedicated Registered Nurses and Advanced Practice Nurses, operating under the guidance of a seasoned Medical Director, is committed to delivering top-notch healthcare services. Specializing in concierge IV Vitamin therapy, peptide therapy, and microneedling with PRP, we bring our expertise to the heart of the Naples area, extending our reach from Marco Island to Cape Coral and every city in between.

Key Points: 
  • The Wellness Lab joins the Haute Beauty Network as a health & wellness expert representing the Naples, FL market.
  • Distinguished as a premier mobile concierge service for vitamin and supplement IV infusions, The Wellness Lab takes a proactive and holistic stance on IV hydration.
  • At The Wellness Lab, we firmly believe that true health and vitality originate from within.
  • Let The Wellness Lab be your partner in achieving your wellness aspirations – because we're dedicated to your well-being from the inside out.